SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001596783-24-000014
Filing Date
2024-02-09
Accepted
2024-02-09 08:04:59
Documents
16
Period of Report
2024-02-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctlt-20240209.htm   iXBRL 8-K 29241
2 EX-99.1 earningsreleaseex991-fy24x.htm EX-99.1 523102
6 image1a.jpg GRAPHIC 45267
  Complete submission text file 0001596783-24-000014.txt   775153

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctlt-20240209.xsd EX-101.SCH 2209
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctlt-20240209_lab.xml EX-101.LAB 24695
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctlt-20240209_pre.xml EX-101.PRE 13095
17 EXTRACTED XBRL INSTANCE DOCUMENT ctlt-20240209_htm.xml XML 2707
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 24611258
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)